Strong Performance of Novartis Pharmaceutical Company Paves Way for Continued Growth

SUGAR LAND--September 4, 2008--Researched by Industrial Info Resources (Sugar Land, Texas)--Multinational pharmaceutical company Novartis AG (NYSE:NVS) (Basel, Switzerland) showed strong global financial growth for the second half of 2008, despite sales declines in the U.S. market. Novartis is involved in the research, manufacturing and distribution of both patented and generic medicines for humans and animals, vaccines, diagnostic equipment and other health-related products. Overall, for the first half of 2008, the company showed a global net sales increase of 11%, reaching about $20.6 billion. Net sales in most countries were up, although compared with the first half of 2007, the U.S., which had net sales of about $6.2 billion, showed an 8% drop.